Peter Ettmayer

11PUBLICATIONS
53CO-AUTHORS
Molecular targetsProteins and peptidesMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 30, 2025
Identification of a Highly Cooperative PROTAC Degrader Targeting GTP-Loaded KRAS(On) Alleles.

Vesna Vetma, Ilaria Puoti, Natalia K Karolak

|Sep 19, 2024
Targeting cancer with small-molecule pan-KRAS degraders.

Johannes Popow, William Farnaby, Andreas Gollner

|Jul 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays.

Thomas Gerstberger, Helmut Berger, Frank H Büttner

|Mar 15, 2021
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS.

Juergen Ramharter, Dirk Kessler, Peter Ettmayer

|Aug 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition.

Marco H Hofmann, Michael Gmachl, Juergen Ramharter

|Feb 07, 2020
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Marco H Hofmann, Rajeswaran Mani, Harald Engelhardt

Pageof 2

Frequent Collaborators

5 joint publications

Alessio Ciulli

5 joint publications

Darryl B McConnell

3 joint publications

William Farnaby

3 joint publications

Claire Whitworth